Hematological diseases and apoptosis.
作者信息
Tohyama K, Kawabata H, Anzai N, Hishita T, Dodo M, Yoshida Y
机构信息
The Department of Laboratory Medicine and Clinical Sciences, Graduate School of Medicine, Kyoto University.
出版信息
Intern Med. 1998 Feb;37(2):188-90. doi: 10.2169/internalmedicine.37.188.
Abstract
摘要
相似文献
1
Hematological diseases and apoptosis.血液学疾病与细胞凋亡。
Intern Med. 1998 Feb;37(2):188-90. doi: 10.2169/internalmedicine.37.188.
2
[Recombinant hematopoietic growth factors in the treatment of various hematologic diseases].[重组造血生长因子在各种血液系统疾病治疗中的应用]
Acta Haematol Pol. 1991;22(1):186-93.
3
[Hematopoietic growth factors].
Postepy Hig Med Dosw. 1991;45(6):461-96.
4
Granulocyte-macrophage colony-stimulating factor: present use and future directions.粒细胞-巨噬细胞集落刺激因子：当前应用与未来方向
Semin Hematol. 1992 Oct;29(4 Suppl 3):38-42.
5
Clinical use of hematopoietic growth factors.造血生长因子的临床应用。
Rev Invest Clin. 1994 Apr;Suppl:33-40.
6
Hematopoietic defects and iPSC disease modeling: lessons learned.造血缺陷与 iPSC 疾病建模：经验教训。
Immunol Lett. 2013 Sep-Oct;155(1-2):18-20. doi: 10.1016/j.imlet.2013.09.018. Epub 2013 Sep 25.
7
Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.干细胞因子作为人类正常和恶性造血过程中的一种存活和生长因子。
Acta Haematol. 1996;95(3-4):257-62. doi: 10.1159/000203893.
8
Biotherapy in hematology: the next decade.
Rev Invest Clin. 1994 Apr;Suppl:8-15.
9
Understanding Hematological Toxicities Using Mathematical Modeling.利用数学模型了解血液学毒性。
Clin Pharmacol Ther. 2018 Oct;104(4):644-654. doi: 10.1002/cpt.1080. Epub 2018 May 1.
10
Hematopoietic stem cells: an overview.造血干细胞：概述
Transfus Apher Sci. 2014 Dec;51(3):68-82. doi: 10.1016/j.transci.2014.10.016. Epub 2014 Oct 17.
Zotero 插件